Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) was the target of unusually large options trading on Wednesday. Investors purchased 2,955 call options on the stock. This represents an increase of approximatel
Amicus Therapeutics (FOLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amicus Therapeutics (FOLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amicus Therapeutics (NASDAQ:FOLD) is set to issue its quarterly earnings data before the market opens on Thursday, May 7th. Analysts expect the company to announce earnings of ($0.28) per share for th
Experts have developed a game that can calm anxiety by working through a puzzle. Now available on Nintendo Switch and Steam!
Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s stock price traded up 6.1% during trading on Friday . The company traded as high as $12.88 and last traded at $12.82, 4,106,425 shares changed hands during
BidaskClub upgraded shares of Amicus Therapeutics (NASDAQ:FOLD) from a hold rating to a buy rating in a report released on Tuesday, BidAskClub reports. Other analysts have also issued reports about th
CRANBURY, N.J., April 24, 2020 -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, May 7,.
Wall Street analysts forecast that Amicus Therapeutics, Inc. (NASDAQ:FOLD) will post $57.21 million in sales for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for Amic
NFL player Russell Okung believes that bitcoin can potentially revolutionize the future of finance, and he's excited about investing in it.
Equities analysts predict that Amicus Therapeutics, Inc. (NASDAQ:FOLD) will post earnings per share of ($0.28) for the current quarter, according to Zacks Investment Research. Five analysts have issue
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE